Dhawan V, Dhoat S, Williams A J, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri K Ray
Regional Movement Disorders Unit, King's College Hospital, UK.
J Neurol Sci. 2006 Oct 25;248(1-2):158-62. doi: 10.1016/j.jns.2006.05.004. Epub 2006 Jun 15.
In this study we have explored the nature and range of sleep dysfunction that occurs in untreated Parkinson's disease (PD) comparing data obtained from the use of the Parkinson's disease sleep scale (PDSS) in an untreated PD patient group compared to advanced PD and healthy controls. 25 untreated (drug-naive, DNPD) PD patients (mean age 66.9 years, range 53-80, 18 males) completed the validated Parkinson's disease sleep scale (PDSS), mean duration of PD was 2.1 years (1-10, up to 4 years in all except one patient with tremulous PD reporting tremor duration of 10 years) and mean Hoehn and Yahr score 1.9 (1-3). Data were compared to 34 advanced PD (mean age 70.2 years, range 51-88, 23 male), mean duration of PD 11 years (range 4-22), mean Hoehn and Yahr score 3.4 (3-5) and PDSS data obtained from 131 healthy controls (mean age 66.6 years, range 50-93, 56 males). Total PDSS scores and PDSS sub-items, except PDSS item 2, were highly significantly different (p<0.001) between DNPD, advanced PD and controls. Controls reported higher mean PDSS scores than both groups of patients, and advanced cases reported lower (mean+/-S.D.) PDSS scores (86.95+/-20.78) than drug-naive (105.72+/-21.5) (p<0.001). Logistic regression analysis showed that items PDSS8 (nocturia), PDSS11 (cramps), PDSS12 (dystonia), PDSS13 (tremor), and PDSS15 (daytime somnolence) were significantly impaired in DNPD compared to controls while PDSS7 (nighttime hallucinations) additionally separated advanced PD from DNPD. In a subgroup of 11 advanced PD cases (mean age 62 years, range=49-84 years, mean Hoehn and Yahr score 2.5, range=1-3) with high Epworth Sleepiness Scale (ESS) scores (mean 14.5), low item 15 PDSS score (mean 4.7) and complaints of severe daytime sleepiness, underwent detailed overnight polysomnography (PSG) studies, all showing abnormal sleep patterns. We conclude that nocturia, nighttime cramps, dystonia, tremor and daytime somnolence seem to be the important nocturnal disabilities in DNPD and some of these symptoms may be reminiscent of "off" period related symptoms even though patients are untreated. Furthermore, polysomnography in "sleepy" PD patients may help diagnose unrecognised conditions such as periodic limb movement of sleep (PLMS), obstructive sleep apnoea (OSA) and REM Sleep Behaviour Disorder.
在本研究中,我们探讨了未经治疗的帕金森病(PD)患者睡眠功能障碍的性质和范围,将未治疗的PD患者组使用帕金森病睡眠量表(PDSS)获得的数据与晚期PD患者和健康对照进行了比较。25例未治疗(初治,DNPD)的PD患者(平均年龄66.9岁,范围53 - 80岁,18例男性)完成了经过验证的帕金森病睡眠量表(PDSS),PD的平均病程为2.1年(1 - 10年,除1例震颤型PD患者报告震颤病程为10年外,其他患者病程均达4年),Hoehn和Yahr平均评分为1.9(1 - 3级)。将数据与34例晚期PD患者(平均年龄70.2岁,范围51 - 88岁,23例男性)、PD平均病程11年(范围4 - 22年)、Hoehn和Yahr平均评分为3.4(3 - 5级)以及131例健康对照(平均年龄66.6岁,范围50 - 93岁,56例男性)获得的PDSS数据进行比较。DNPD组、晚期PD组和对照组之间,除PDSS第2项外,PDSS总分及各子项均存在高度显著差异(p<0.001)。对照组报告的PDSS平均得分高于两组患者,晚期病例报告的PDSS得分(平均值±标准差)(86.95±20.78)低于初治患者(105.72±21.5)(p<0.001)。逻辑回归分析显示,与对照组相比,DNPD组的PDSS8(夜尿症)、PDSS11(抽筋)、PDSS12(肌张力障碍)、PDSS13(震颤)和PDSS15(日间嗜睡)项目明显受损,而PDSS7(夜间幻觉)项目进一步将晚期PD与DNPD区分开来。在11例晚期PD病例(平均年龄62岁,范围49 - 84岁,Hoehn和Yahr平均评分为2.5,范围1 - 3级)的亚组中,这些患者Epworth嗜睡量表(ESS)得分较高(平均14.5)、PDSS第15项得分较低(平均4.7)且主诉有严重的日间嗜睡,对其进行了详细的夜间多导睡眠图(PSG)研究,所有结果均显示睡眠模式异常。我们得出结论,夜尿症、夜间抽筋、肌张力障碍、震颤和日间嗜睡似乎是DNPD患者重要的夜间功能障碍,其中一些症状可能类似于“关”期相关症状,即使患者未接受治疗。此外,对“嗜睡”的PD患者进行多导睡眠图检查可能有助于诊断未被识别的病症,如睡眠周期性肢体运动(PLMS)、阻塞性睡眠呼吸暂停(OSA)和快速眼动睡眠行为障碍。